What move does the options market price into CytomX Therapeutics's report?

Implied ±23.7%, either direction.

CTMXNasdaqPharmaceutical Preparations

CytomX Therapeutics, Inc. (CTMX) earnings date, market-implied expected move, and options open interest by expiry

2.35

+0.17 · +7.72%

post 2.35 −0.01%

After hours16:00 ETdelayed

Open2.19Volume3.4MMkt cap$475.0M

Day2.19 – 2.35100%52-wk2.14 – 8.213%

CTMX

CytomX Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±23.7%implied · report alone

1.893.06

straddle ±30.1%

spot 2.47exp Nov 20ATM strike 2ATM straddle 0.88IV 237%

Nov 4 closereport share · term structure

Expected move

Inputs

Next report

Nov 5

after close · in 1 day

est.Q3 FY26

Calendar

Next report

Last report

+2.67%

vs ±14.0% implied · ×0.19

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Linked news

News

Largest filed tie

13F top-10 QoQ

+25.29%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

179 managers

Top fund weight

0.28%

CTMX weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

CytomX Therapeutics (CTMX) is expected to report on Nov 5 after close (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 6 '26confirmed±14.0%▲+2.67%×0.19

quarterimplied−15%0+15%realized×

Q2 FY26±14.0%▲+2.67%×0.19

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 3 close

6.33OI · 4 expiries · Nov 3 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

14,1350%Nov 2016d2,2340%

12+500%Dec 1844d0.062010%0.06

6490%Jan 1572d0.154,3960%0.15

47+2%Feb 19107d0.076280%0.07

ExpiryPutsCallsP/C

Nov 2016d14,1350%2,2340%6.33

Dec 1844d12+500%2010%0.06

Jan 1572d6490%4,3960%0.15

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±30.1%

Funds 4

XBI±0.1%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

−1457.40%as filednet margin · revenue −86.18% QoQ · −92.40% YoY

Revenue$1M−86.18%

Gross profit$1M100.00%−86.18%

Operating income−$24M−1677.08%−20.89%

Pre-tax income−$21M−13.29%

Net income−$21M−1457.40%−13.25%

Cost of revenue$0—

Operating expenses$25M−15.81%

Tax$60,000+1.69%

Other income$3M+114.09%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 4 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

FOMC ×2.99· ±12.2% vs ±4.1% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±12.2%8 of 24×2.99

PPIproducer prices±4.5%4 of 10×1.11

GDPgross domestic product±4.5%11 of 19×1.11

CPROFcorporate profits±4.1%6 of 12×1.00

PCEpersonal income & outlays±3.5%8 of 19×0.84

NFPjobs report±2.6%6 of 10×0.63

CPIconsumer prices±2.4%3 of 10×0.58

Bar = avg |move| to ±13% · tick = ±4.1% avg day · ×base = |move| ÷ ±4.1% · min 6 releases

Earnings history

EPS — · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	—	—
Q1 FY26	—	—	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod